Zobrazeno 1 - 10
of 372
pro vyhledávání: '"Sujenthiran, A"'
Autor:
Pall Jonsson, Danielle Bargo, Seamus Kent, Philani Mpofu, Harlan Pittell, Brad Groves, Ivy Altomare, Amanda Copeland, Shrujal Baxi, Arun Sujenthiran, Blythe Adamson
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Objectives Examine whether data from early access to medicines in the USA can be used to inform National Institute for Health and Care Excellence (NICE) health technology assessments (HTA) in oncology.Design Retrospective cohort study.Setting Oncolog
Externí odkaz:
https://doaj.org/article/42e89803cf02448a9253c50a3750dc27
Autor:
Sujenthiran, Arunan, Parry, Matthew G., Dodkins, Joanna, Nossiter, Julie, Morris, Melanie, Berry, Brendan, Nathan, Arjun, Cathcart, Paul, Clarke, Noel W., Payne, Heather, van der Meulen, Jan, Aggarwal, Ajay
Publikováno v:
In Clinical and Translational Radiation Oncology May 2023 40
Autor:
Fankhauser, Christian D., Parry, Matthew G., Ali, Adnan, Cowling, Thomas E., Nossiter, Julie, Sujenthiran, Arun, Berry, Brendan, Morris, Melanie, Aggarwal, Ajay, Payne, Heather, van der Meulen, Jan, Clarke, Noel W.
Publikováno v:
In European Journal of Cancer March 2023 181:70-78
Autor:
Parry, Matthew G.1,2 (AUTHOR) mparry@rcseng.ac.uk, Sujenthiran, Arunan2,3 (AUTHOR), Nossiter, Julie1,2 (AUTHOR), Morris, Melanie1,2 (AUTHOR), Berry, Brendan1,2 (AUTHOR), Nathan, Arjun2,4 (AUTHOR), Aggarwal, Ajay1,5 (AUTHOR), Payne, Heather6 (AUTHOR), van der Meulen, Jan1 (AUTHOR), Clarke, Noel W.7 (AUTHOR)
Publikováno v:
BJU International. Nov2023, Vol. 132 Issue 5, p568-574. 7p.
Autor:
Arunan Sujenthiran, Matthew G. Parry, Joanna Dodkins, Julie Nossiter, Melanie Morris, Brendan Berry, Arjun Nathan, Paul Cathcart, Noel W. Clarke, Heather Payne, Jan van der Meulen, Ajay Aggarwal
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 40, Iss , Pp 100622- (2023)
Purpose There is debate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation in addition to prostate bed radiotherapy when used to treat disease recurrence following radical prostatectomy. We compared toxicity from radiation th
Externí odkaz:
https://doaj.org/article/184f14defce340beaa13d2814db16f0a
Autor:
Aggarwal, Ajay *, Nossiter, Julie, Parry, Matthew, Sujenthiran, Arunan, Zietman, Anthony, Clarke, Noel, Payne, Heather, van der Meulen, Jan
Publikováno v:
In The Lancet Oncology May 2021 22(5):e207-e215
Autor:
Parry, Matthew G., Nossiter, Julie, Cowling, Thomas E., Sujenthiran, Arunan, Berry, Brendan, Cathcart, Paul, Clarke, Noel W., Payne, Heather, van der Meulen, Jan, Aggarwal, Ajay
Publikováno v:
In Radiotherapy and Oncology February 2021 155:48-55
Autor:
Mieke Van Hemelrijck, Muhammad Imran Omar, Jihong Zong, Katharina Beyer, Lisa Moris, Michael Lardas, Anna Haire, Francesco Barletta, Simone Scuderi, Eleni Vradi, Giorgio Gandaglia, Steven MacLennan, Bahman Farahmand, Sara J Maclennan, Zsuzsanna Devecseri, Alex Asiimwe, Laurence Collette, Anders Bjartell, James Ndow, Alberto Briganti, Thomas Van den Broeck, Riccardo Campi, Isabella Greco, Mauro Gacci, Megan Molnar, Ronald Herrera, Monique J Roobol, Abdul Rauf, Kirill Shiranov, Saeed Dabestani, Sujenthiran Arun
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Objectives As part of the PIONEER Consortium objectives, we have explored which diagnostic and prognostic factors (DPFs) are available in relation to our previously defined clinician and patient-reported outcomes for prostate cancer (PCa).Design We p
Externí odkaz:
https://doaj.org/article/6a9eea08bc0d4eb2953468c275589308
Autor:
Sujenthiran, A. †, ‡, ∗, Parry, M. †, §, ∗, Nossiter, J. †, Berry, B. †, Cathcart, P.J. ‡, Clarke, N.W. ||, Payne, H. ¶, van der Meulen, J. §, Aggarwal, A. §, ∗∗
Publikováno v:
In Clinical Oncology August 2020 32(8):501-508
Autor:
M. G. Parry, T. E. Cowling, A. Sujenthiran, J. Nossiter, B. Berry, P. Cathcart, A. Aggarwal, H. Payne, J. van der Meulen, N. W. Clarke, V. J. Gnanapragasam
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background The five-tiered Cambridge Prognostic Group (CPG) classification is a better predictor of prostate cancer-specific mortality than the traditional three-tiered classification (low, intermediate, and high risk). We investigated radic
Externí odkaz:
https://doaj.org/article/07e55a6523a24f5899abcb57f2dd5e2e